BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35925221)

  • 1. [Differential diagnosis of reactive cytopenias].
    Menter T; Dirnhofer S; Tzankov A
    Pathologie (Heidelb); 2022 Jul; 43(4):263-270. PubMed ID: 35925221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bone marrow histology of cytopenias : Contribution to hematological differential diagnosis].
    Kreipe H
    Pathologie (Heidelb); 2024 Mar; 45(2):148-158. PubMed ID: 38381371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syndromes predisposing to leukemia are a major cause of inherited cytopenias in children.
    Gilad O; Dgany O; Noy-Lotan S; Krasnov T; Yacobovich J; Rabinowicz R; Goldberg T; Kuperman AA; Abu-Quider A; Miskin H; Kapelushnik N; Mandel-Shorer N; Shimony S; Harlev D; Ben-Ami T; Adam E; Levin C; Aviner S; Elhasid R; Berger-Achituv S; Chaitman-Yerushalmi L; Kodman Y; Oniashvilli N; Hameiri-Grosman M; Izraeli S; Tamary H; Steinberg-Shemer O
    Haematologica; 2022 Sep; 107(9):2081-2095. PubMed ID: 35295078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypopituitarism and hematological abnormalities mimicking myelodysplastic syndrome. Report of four cases].
    Rudzki Z; Matynia A; Przybylik-Mazurek E; Darczuk A; Szybiński Z; Piatkowska-Jakubas B; Wójcik M; Skotnicki AB
    Pol Arch Med Wewn; 2003 Sep; 110(3):1003-11. PubMed ID: 14699694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of a scoring system to establish the probability of myelodysplastic syndrome in patients with unexplained cytopenias or macrocytosis.
    Rauw J; Wells RA; Chesney A; Reis M; Zhang L; Buckstein R
    Leuk Res; 2011 Oct; 35(10):1335-8. PubMed ID: 21704372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Myelodysplastic syndromes--an overview for the practitioner].
    Solenthaler M; Tobler A
    Ther Umsch; 2004 Feb; 61(2):117-24. PubMed ID: 15018394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paraneoplastic marrow alterations in patients with cancer.
    Castello A; Coci A; Magrini U
    Haematologica; 1992; 77(5):392-7. PubMed ID: 1483587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis, classification, and course of myelodysplastic syndromes.
    McKenna RW; Allison PM
    Clin Lab Med; 1990 Dec; 10(4):683-706. PubMed ID: 2272170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow findings in severe fever with thrombocytopenia syndrome: prominent haemophagocytosis and its implication in haemophagocytic lymphohistiocytosis.
    Kim N; Kim KH; Lee SJ; Park SH; Kim IS; Lee EY; Yi J
    J Clin Pathol; 2016 Jun; 69(6):537-41. PubMed ID: 26908283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The current approach to the diagnosis of myelodysplastic syndromes
    Weinberg OK; Hasserjian RP
    Semin Hematol; 2019 Jan; 56(1):15-21. PubMed ID: 30573039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dyspoietic changes associated with hepatosplenic T-cell lymphoma are not a manifestation of a myelodysplastic syndrome: analysis of 25 patients.
    Yabe M; Medeiros LJ; Tang G; Wang SA; P Patel K; Routbort M; Bhagat G; Bueso-Ramos CE; Jorgensen JL; Luthra R; Chen W; Muzzafar T; Kanagal-Shamanna R; Khoury JD; Daneshbod Y; Davanlou M; Li S; Young KH; Miranda RN
    Hum Pathol; 2016 Apr; 50():109-17. PubMed ID: 26997444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of dysmyelopoiesis in cats: 34 cases (1996-2005).
    Weiss DJ
    J Am Vet Med Assoc; 2006 Mar; 228(6):893-7. PubMed ID: 16536701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The challenging world of cytopenias: distinguishing myelodysplastic syndromes from other disorders of marrow failure.
    DeZern AE; Sekeres MA
    Oncologist; 2014 Jul; 19(7):735-45. PubMed ID: 24899643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biology of the bone marrow microenvironment and myelodysplastic syndromes.
    Rankin EB; Narla A; Park JK; Lin S; Sakamoto KM
    Mol Genet Metab; 2015; 116(1-2):24-8. PubMed ID: 26210353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Criteria for suspecting a myelodysplastic syndrome].
    Varet B; Ifrah N
    Rev Prat; 2010 Dec; 60(10):1404-7. PubMed ID: 21425539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoreactivity of MIC2 (CD99) and terminal deoxynucleotidyl transferase in bone marrow clot and core specimens of acute myeloid leukemias and myelodysplastic syndromes.
    Kang LC; Dunphy CH
    Arch Pathol Lab Med; 2006 Feb; 130(2):153-7. PubMed ID: 16454553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cold autoimmune hemolytic anemia with myelodysplastic syndrome: Not just an "Open and Shut case".
    Mutreja D; Paliwal G; Mangal V; Biswas AK
    Indian J Pathol Microbiol; 2022; 65(1):195-197. PubMed ID: 35074995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myelodysplastic syndromes.
    Adès L; Itzykson R; Fenaux P
    Lancet; 2014 Jun; 383(9936):2239-52. PubMed ID: 24656536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.